News

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.
A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...
The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...
Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the immune system mistakenly attacks the lining of the ...
Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside other inflammatory conditions.
US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis: Valencia, California Saturday, August 2, 2025, 17:00 Hrs [IST] ...
The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...
The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...
The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...
While rheumatoid arthritis can affect adults of any age, it’s most commonly starts among people between the ages of 40 and 60 ...
Rheumatoid arthritis (RA) impacts thousands of Australians each year, causing pain, stiffness, and a steady decline in ...